
Diageo, Regencell Bioscience, and UP Fintech are the three Chinese stocks to watch today, according to MarketBeat’s stock screener tool. Chinese stocks are equity securities of companies that are incorporated in, or derive a substantial portion of their revenue from, mainland China; they can trade on domestic exchanges (Shanghai, Shenzhen), the Hong Kong Stock Exchange, or overseas as ADRs/GDRs. For investors, they provide direct exposure to the Chinese economy but carry specific risks including regulatory and political intervention, differing accounting and disclosure standards, capital controls and currency risk, and greater market volatility. These companies had the highest dollar trading volume of any Chinese stocks within the last several days.
Diageo (DEO)
Diageo plc, together with its subsidiaries, engages in the production, marketing, and sale of alcoholic beverages. The company offers scotch, gin, vodka, rum, raki, liqueur, wine, tequila, Chinese white spirits, cachaça, and brandy, as well as beer, including cider and flavored malt beverages. It also provides Chinese, Canadian, Irish, American, and Indian-Made Foreign Liquor whiskies, as well as flavored malt beverages, ready to drink, and non-alcoholic products.
Regencell Bioscience (RGC)
Regencell Bioscience Holdings Limited operates a Traditional Chinese medicine (TCM) bioscience company. It focuses on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degeneration, primarily attention deficit hyperactivity disorder and autism spectrum disorder.
Read Our Latest Research Report on RGC
UP Fintech (TIGR)
UP Fintech Holding Limited provides online brokerage services focusing on Chinese investors. The company has developed a brokerage platform, which allows investor to trade stocks, options, warrants, and other financial instruments that can be accessed through its APP and website. It offers brokerage and value-added services, including investor education, community engagement, and IR platform services.
Read Our Latest Research Report on TIGR
See Also
- MarketBeat’s Top Five Stocks to Own in January 2026
- Intuitive Surgical Just Proved the Growth Engine Still Runs
- Johnson & Johnson Quietly Triggers a Trend Following Buy Signal
- Ally Financial Pops on Q4 Earnings Beat and $2 Billion Buyback
- Netflix Stock Drops 35%+ After Q4 as WBD Deal Risk Rises
- Microsoft Slumps Heading Into Earnings—Here’s What Matters Most
